Lenalidomide, rituximab and dexamethasone for the treatment of recurrent/refractory or elderly newly diagnosed patients with primary central nervous system lymphoma: 5 cases report and literature review.
- VernacularTitle:来那度胺、利妥昔单抗联合地塞米松治疗复发/难治或老年初治原发中枢神经系统弥漫性大B细胞淋巴瘤五例报告及文献复习
- Author:
Jie Fei BAI
1
;
Ru FENG
1
;
Hui Xiu HAN
1
;
Ting WANG
1
;
Jiang Tao LI
1
;
Chun Li ZHANG
1
;
Hui LIU
1
Author Information
- Publication Type:Journal Article
- MeSH: Aged; Antineoplastic Combined Chemotherapy Protocols/therapeutic use*; Central Nervous System Neoplasms/drug therapy*; Dexamethasone/therapeutic use*; Humans; Lenalidomide/therapeutic use*; Lymphoma/drug therapy*; Neoplasm Recurrence, Local; Rituximab/therapeutic use*; Treatment Outcome
- From: Chinese Journal of Hematology 2019;40(12):1047-1049
- CountryChina
- Language:Chinese
